Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M207Revenue $M28.6Net Margin (%)-213.4Altman Z-Score-6.8
Enterprise Value $M72.8EPS $-0.7Operating Margin %-214.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.0Pre-tax Margin (%)-213.4Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio3.9Cash flow > EarningsY
Price/Sales7.25-y EBITDA Growth Rate %--Current Ratio3.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-39.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-52.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M88.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with RIGL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RIGLCharles Brandes 2015-09-30 Reduce$2.36 - $3.35
($2.98)
$ 2.34-21%Reduce -44.07%25,000
RIGLCharles Brandes 2015-03-31 Buy $2.06 - $3.68
($2.74)
$ 2.34-15%New holding44,700
RIGLCharles Brandes 2014-09-30 Sold Out $1.97 - $3.84
($2.81)
$ 2.34-17%Sold Out0
RIGLCharles Brandes 2014-03-31 Buy $2.7 - $4.75
($3.53)
$ 2.34-34%New holding15,000
RIGLGeorge Soros 2011-12-31 Sold Out -0.0019%$6.68 - $8.3
($7.59)
$ 2.34-69%Sold Out0
RIGLFirst Eagle Investment 2011-06-30 Sold Out $7.18 - $9.19
($8.08)
$ 2.34-71%Sold Out0
RIGLGeorge Soros 2011-06-30 Buy $7.18 - $9.19
($8.08)
$ 2.34-71%New holding14,500
RIGLFirst Eagle Investment 2011-03-31 Buy $6.54 - $7.74
($7.06)
$ 2.34-67%New holding46,700
RIGLGeorge Soros 2010-09-30 Sold Out $6.94 - $8.8
($8.11)
$ 2.34-71%Sold Out0
RIGLGeorge Soros 2010-03-31 Add$7.41 - $9.83
($8.55)
$ 2.34-73%Add 34.29%14,100
RIGLGeorge Soros 2009-12-31 Buy $6.08 - $9.86
($7.86)
$ 2.34-70%New holding10,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RIGL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


RIGL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-06-10Sell41,666$3.68-36.41view
PAYAN DONALD GEVP, Pres. Discovery&Research 2015-04-01Sell10,000$3.75-37.6view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.225.41view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.225.41view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-09-03Sell20,000$2.56-8.59view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-02-24Sell20,000$3.71-36.93view
BVF PARTNERS L P/IL10% Owner 2013-11-19Sell484,622$2.64-11.36view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy32,700$3.47-32.56view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2012-09-13Sell4,151$10.43-77.56view
Maynard Ryan DEVP & CFO 2012-09-12Sell23,302$10.67-78.07view

Quarterly/Annual Reports about RIGL:

    News about RIGL:

    Articles On GuruFocus.com
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 
    Rigel Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 01 2011 

    More From Other Websites
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 29 2016
    Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP (FIT) Jan 28 2016
    Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP (FIT) Jan 28 2016
    Rigel Reviews Recent Progress and Announces Presentation at the 34th Annual J.P. Morgan Healthcare... Jan 07 2016
    Rigel Reviews Recent Progress and Announces Presentation at the 34th Annual J.P. Morgan Healthcare... Jan 07 2016
    Direction of Market Influences - Free Research on Rex Energy, Kratos Defense and Security Solutions,... Dec 15 2015
    Is XenoPort, Inc. (XNPT) A Good Stock To Buy? Dec 14 2015
    RIGEL PHARMACEUTICALS INC Financials Dec 08 2015
    What Do Hedge Funds Think of Wi-LAN Inc – US listing (WILN)? Nov 29 2015
    A look at Equity Market Momentum - Research on Telecommunication Systems, Rigel Pharmaceuticals,... Nov 18 2015
    Edited Transcript of RIGL earnings conference call or presentation 3-Nov-15 10:00pm GMT Nov 04 2015
    Rigel reports 3Q loss Nov 03 2015
    Rigel reports 3Q loss Nov 03 2015
    Rigel Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today Nov 03 2015
    Rigel Announces Third Quarter 2015 Financial Results Nov 03 2015
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 03 2015
    Rigel Announces Third Quarter 2015 Financial Results Nov 03 2015
    Rigel Announces Conference Call and Webcast to Report Third Quarter 2015 Financial Results Oct 27 2015
    Rigel Announces Conference Call and Webcast to Report Third Quarter 2015 Financial Results Oct 27 2015
    Rigel Pharmaceuticals, Inc. Earnings Q2, 2015 Sep 30 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK